These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2548448)
1. Inhibition of platelet aggregation by idebenone and the mechanism of the inhibition. Suno M; Terashita Z; Nagaoka A Arch Gerontol Geriatr; 1989 May; 8(3):313-21. PubMed ID: 2548448 [TBL] [Abstract][Full Text] [Related]
2. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852 [TBL] [Abstract][Full Text] [Related]
3. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
4. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369 [TBL] [Abstract][Full Text] [Related]
5. Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood. Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):149-54. PubMed ID: 1808624 [TBL] [Abstract][Full Text] [Related]
6. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267 [TBL] [Abstract][Full Text] [Related]
8. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function. Fitzpatrick FA; Gorman RR Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities. Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481 [TBL] [Abstract][Full Text] [Related]
10. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. Miller OV; Ayer DE; Gorman RR Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815 [TBL] [Abstract][Full Text] [Related]
13. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood. Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784 [TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of the inhibition of platelet aggregation and release induced by high levels of arachidonate. Linder BL; Goodman DS Blood; 1982 Aug; 60(2):436-45. PubMed ID: 6284285 [TBL] [Abstract][Full Text] [Related]
15. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062 [TBL] [Abstract][Full Text] [Related]
16. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase. Kowalska MA; Rao AK; Disa J Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717 [TBL] [Abstract][Full Text] [Related]
17. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses. Gross PL; Rand ML; Barrow DV; Packham MA Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. Gasser JA; Betterridge DJ J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Sheu JR; Hung WC; Lee YM; Yen MH Eur J Pharmacol; 1996 Dec; 318(2-3):469-75. PubMed ID: 9016940 [TBL] [Abstract][Full Text] [Related]
20. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium. Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]